This inventor holds 12 USPTO granted patents and 5 published patent applications and 7 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Evotec Ag. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Abingdon Oxfordshire, GB (2014)
- Abingdon, GB (2014 - 2024)
Company Filing History:
5 out of 12,268 
4 out of 387 
2 out of 24 
Years Active: 2014-2025
Title: Innovations by Adam James Davenport: A Trailblazer in Pharmaceutical Patents
Introduction
Adam James Davenport, a notable inventor based in Abingdon, GB, has made significant contributions to the field of pharmaceuticals through his innovative work. With a total of 12 patents to his name, Davenport has consistently focused on the development of compounds that target vital receptors in the human body, providing new avenues for medical treatment.
Latest Patents
Among his latest inventions, Davenport has developed carboxylic acid aromatic amides as antagonists of the bradykinin B1 receptor. This invention details compounds represented by a general formula, providing insights into pharmaceutical compositions and combinations that can be utilized for the treatment or prophylaxis of various diseases. These compounds may act as sole agents or in conjunction with other active ingredients to enhance therapeutic efficacy. Furthermore, he has contributed to similar compounds of carboxylic acid aromatic amides that expand upon their medicinal applications.
Career Highlights
Davenport has had a distinguished career working with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. His tenure at these organizations has allowed him to combine his inventive talents with commercial applications, ensuring that his research culminates in beneficial treatments for patients.
Collaborations
Throughout his career, Davenport has collaborated with several notable professionals in the industry. He has worked alongside Andrea Rotgeri and Jens Nagel, who have contributed to his projects and innovations in various capacities. Their teamwork showcases the importance of collaboration in research and development, further driving advancements in pharmaceutical sciences.
Conclusion
Adam James Davenport stands out as an accomplished inventor in the pharmaceutical field, with a strong focus on innovative compounds that address significant health challenges. With his progressive patents and collaborative efforts, he continues to impact the industry positively, paving the way for future advancements in medical treatments. His work exemplifies the essence of innovation, highlighting the critical role inventors play in shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile